ChartRow logo
PBH
$49.36-0.70%
as of close, Oct 20, 2026
☾ AH $49.36 -0.70%
PeersMRNALLYMDTUNHJNJTMO
Share this page

PBH financial statements

The full income statement, balance sheet, and cash-flow statement for Prestige Consumer Healthcare Inc. (PBH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 49.6M2024-09 49.4M2024-12 49.5M2025-03 49.4M2025-06 49.2M2025-09 48.1M2025-12 47.3M2026-03 47.4M2026-06 47.4M-4.4% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022
Income Statementas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Revenue1.09B-4.3%1.14B+1.1%1.13B-0.2%1.13B+3.8%1.09B+15.2%
596M-6.1%634M+1.6%624M-0.1%625M+0.7%621M+13.4%
Cost of revenue493M-2.0%503M+0.5%501M-0.3%502M+7.8%466M+17.8%
286M-3.9%298M+5.6%282M-56.5%648M+122.8%291M+16.3%
Selling, general & administrative116M+7.6%108M+1.9%106M-1.1%107M-0.1%107M+29.3%
General & administrative116M+7.6%108M+1.9%106M-1.1%107M-0.1%107M+29.3%
Amortization of intangibles17.9M-1.9%18.3M-7.7%19.8M-11.1%22.3M+3.6%21.5M+9.8%
Provision for credit losses10.3M0.000.00——
Operating income309M-8.1%337M-1.7%342M+1627.7%-22.4M-106.8%330M+10.9%
Interest expense—1.80M-65.4%5.20M+18.2%4.40M-93.2%64.3M-21.9%
Net interest income-42.3M+11.1%-47.6M+29.1%-67.2M+2.9%-69.2M-7.6%-64.3M
Other non-operating income-9.57M-93.3%-4.95M-755.3%756K+132.4%-2.34M-122.1%-1.05M-177.0%
Pre-tax income257M-9.4%284M+3.0%276M+393.9%-93.9M-135.8%262M+28.6%
Income tax67.2M-3.4%69.6M+4.3%66.7M+674.4%-11.6M-120.3%57.1M+44.8%
Net income190M-11.3%215M+2.5%209M+354.3%-82.3M-140.1%205M+24.7%
$3.91-8.9%$4.29+2.9%$4.17+352.7%-$1.65-140.8%$4.04+24.3%
EPS (basic)$3.93-9.0%$4.32+2.6%$4.21+355.2%-$1.65-140.3%$4.09+24.7%
Weighted-avg shares (basic)48.5M-2.5%49.7M-0.1%49.8M-0.3%49.9M-0.7%50.3M+0.1%
Weighted-avg shares (diluted)48.7M-2.7%50.1M-0.2%50.2M+0.6%49.9M-1.9%50.8M+0.5%
Balance Sheetas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
431M-3.8%448M+19.5%375M-4.3%392M+33.6%293M+8.7%
Cash & equivalents63.9M-34.8%97.9M+110.6%46.5M-20.6%58.5M+115.2%27.2M-15.8%
Accounts receivable192M-1.2%194M+9.9%177M+5.8%167M+19.9%139M+21.5%
Inventory159M+7.7%148M+6.5%139M-14.4%162M+34.7%120M+4.7%
Prepaid expenses16.6M+96.2%8.44M-35.5%13.1M+217.8%4.12M-35.8%6.41M-18.9%
3.49B+2.7%3.40B+2.5%3.32B-1.1%3.35B-8.6%3.67B+7.0%
Property, plant & equipment122M+63.2%74.5M-2.6%76.5M+8.7%70.4M-1.2%71.3M+1.8%
Operating lease right-of-use27.8M-1.6%28.2M+150.2%11.3M-24.4%14.9M-26.7%20.4M-14.1%
Goodwill581M+10.2%527M-0.1%528M+0.0%528M-8.9%579M+0.2%
Intangible assets2.30B+0.2%2.30B-1.1%2.32B-0.9%2.34B-13.2%2.70B+8.9%
Other non-current assets10.9M+232.1%3.27M-42.8%5.72M+90.5%3.00M-8.2%3.27M+14.3%
121M+13.4%107M-8.9%117M-27.2%161M+12.1%143M+17.4%
Accounts payable22.8M+20.4%18.9M-51.4%39.0M-37.9%62.7M+12.5%55.8M+21.3%
Short-term & current debt
0.00————
Current lease liability6.91M+14.3%6.05M+29.8%4.66M-32.7%6.93M+8.9%6.36M+8.6%
Finance lease liability (current)2.66M+6.7%2.49M+66.7%1.49M-47.3%2.83M+3.0%2.75M+6.3%
1.61B+2.5%1.57B-5.8%1.66B-12.8%1.91B-8.9%2.09B+1.1%
Long-term debt994M+0.2%992M-12.6%1.14B-15.7%1.35B-8.9%1.48B-0.2%
Non-current lease liability21.0M-7.8%22.7M+202.0%7.53M-23.8%9.88M-38.6%16.1M-18.4%
Operating lease liability (total)27.9M-3.2%28.8M+136.2%12.2M-27.5%16.8M-25.2%22.4M-12.2%
Finance lease liability (total)20.6M-10.8%23.1M+1287.4%1.67M-63.0%4.50M-37.9%7.25M-22.9%
Finance lease liability18.0M-12.9%20.6M+11890.7%172K-89.7%1.67M-63.0%4.50M-34.0%
Deferred tax liabilities447M+6.6%420M+4.0%404M+6.1%380M-14.5%445M+2.5%
Other non-current liabilities5.58M+3.5%5.39M-41.3%9.19M+12.5%8.16M+9.1%7.48M-13.1%
1.89B+2.9%1.83B+10.9%1.66B+14.4%1.45B-8.3%1.58B+16.1%
Preferred stock0.000.000.000.000.00
Common stock562K+0.4%560K+0.9%555K+1.3%548K+0.7%544K+0.7%
Additional paid-in capital609M+2.5%593M+4.6%567M+6.0%535M+3.8%516M+3.2%
Retained earnings1.75B+12.2%1.56B+16.0%1.34B+18.5%1.13B-6.8%1.21B+20.4%
Treasury stock439M+58.5%277M+26.2%220M+16.1%189M+41.5%134M+2.2%
Accumulated other comprehensive income-28.4M+24.7%-37.7M-9.2%-34.5M-9.3%-31.6M-65.8%-19.0M+3.9%
Total liabilities & equity3.49B+2.7%3.40B+2.5%3.32B-1.1%3.35B-8.6%3.67B+7.0%
Common shares issued56.2M+0.4%56.0M+0.9%55.5M+1.2%54.9M+0.8%54.4M+0.8%
Common shares outstanding56.2M+0.4%56.0M+0.9%55.5M+1.2%54.9M+0.8%54.4M+0.8%
Shares outstanding (cover)47.4M-4.1%49.4M-1.0%49.9M+0.4%49.7M-1.2%50.3M+0.7%
Cash Flowas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
258M+2.4%252M+1.0%249M+8.4%230M-11.6%260M+10.3%
Depreciation & amortization31.3M+3.6%30.2M-1.6%30.7M-6.0%32.6M+1.7%32.1M+6.4%
Intangible amortization17.9M-1.9%18.3M-7.7%19.8M-11.1%22.3M+3.6%21.5M+9.8%
Share-based compensation10.8M-2.9%11.2M-20.4%14.0M+12.9%12.4M—
Deferred income taxes22.7M+57.5%14.4M-37.5%23.1M+138.0%-60.8M-708.9%9.98M-46.4%
Change in receivables3.69M-77.4%16.3M+158.3%6.32M-74.6%24.9M+1.1%24.7M+166.9%
Change in inventory1.60M-82.9%9.31M+138.1%-24.4M-157.9%42.2M+6468.8%-663K+77.7%
Change in payables-151K+99.2%-19.4M+22.3%-25.0M-444.0%7.26M-20.7%9.15M+152.8%
-137M-684.1%-17.5M+13.2%-20.1M-73.6%-11.6M+95.5%-257M-1053.2%
Capital expenditure11.2M+35.9%8.22M-13.9%9.55M+22.7%7.78M-19.3%9.64M-56.7%
Free cash flow246M+1.3%243M+1.6%239M+7.9%222M-11.3%250M+17.3%
Acquisitions124M+1399.8%8.25M-21.9%10.6M0.00-100.0%247M
Other investing activities1.93M+97.0%978K0.00-100.0%3.80M+2246.9%-177K
-156M+14.3%-182M+24.5%-241M-29.7%-186M-2355.4%-7.57M+97.3%
Long-term debt issued0.000.000.000.000.00-100.0%
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased156M+203.4%51.5M+106.0%25.0M-50.0%50.0M0.00-100.0%
Dividends paid0.000.000.000.000.00
Other financing activities-246K0.000.00——
FX effect on cash1.26M+319.9%-573K-418.3%180K+118.3%-982K-2.4%-959K-126.7%
Net change in cash-34.0M-166.2%51.4M+527.7%-12.0M-138.4%31.3M+711.8%-5.12M+91.8%
Interest paid43.8M-8.3%47.8M-24.4%63.2M+16.6%54.2M-11.6%61.4M-23.6%
Income taxes paid45.9M-11.8%52.1M-12.6%59.6M+46.4%40.7M-12.5%46.6M+35.4%
Valuation Ratiosas ofMar 31 ’26as ofMar 31 ’25as ofMar 31 ’24as ofMar 31 ’23as ofMar 31 ’22
Market cap2.81B-33.9%4.25B+17.9%3.60B+15.8%3.11B+16.9%2.66B+21.0%
P/E14.8×-25.5%19.8×——13.0×-3.0%
P/S2.6×-30.9%3.7×+17.6%3.2×+15.1%2.8×+12.7%2.4×+5.0%
P/B1.5×-35.7%2.3×+2.9%2.3×+4.7%2.2×+27.5%1.7×+4.2%
P/FCF11.4×-34.8%17.5×+12.5%15.5×+10.7%14.0×+31.9%10.6×+3.1%
Earnings yield6.8%+34.2%5.1%——7.7%+3.1%
FCF yield8.8%+53.3%5.7%-11.1%6.4%-9.7%7.1%-24.2%9.4%-3.0%
Source filing10-K10-K10-K10-K10-K

About this data

Source: PBH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PBH filings on SEC EDGAR → Not investment advice.